AEM vs ECL

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

Ecolab exhibits stable financial health with a Piotroski F-Score of 6/9, though it currently trades at a significant premium to its Graham Number ($75.38) and Intrinsic Value ($215.06). While the company demonstrates strong profitability with an ROE of 22.52% and robust earnings growth of 20.2%, its valuation is stretched as evidenced by a PEG ratio of 2.49 and a P/E of 36.75. Bearish technical trends and negative insider sentiment contrast with a bullish analyst consensus, suggesting a high-quality company that is currently overpriced for new entries.